logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-10. Distribution of clients entering treatment according to age and primary drug - EU overall summary in 2005 [see all tables in this series...]

Part (iv) Distribution of all outpatient clients by primary drug for each age group

Substance<1515-1920-2425-2930-3435-3940-4445+Age knownAge not known
Opioids4.816.743.657.364.067.468.059.2167149388
Cocaine1.99.015.218.619.317.617.314.551098114
Stimulants4.07.86.44.23.02.62.13.31355323
Hypnotics and sedatives0.60.91.11.31.82.33.09.06454181
Hallucinogens0.20.40.30.20.10.10.10.16442
Volatile substances5.70.80.30.10.10.10.10.18432
Cannabis 81.163.231.416.710.08.17.59.567184217
Other substances 1.71.21.71.51.71.81.94.45658132
Total3009328416308465847567774416227122197413125831059

Notes:

 The countries supplying data are: 

 BG, CZ, DK, DE, IE, EL, ES, FR, IT, CY, LT, LU, HU, MT, NL, SK, FI, SE, UK 

 Last data available from Spain refer to year of treatment 2004.               

 The number of treatment clients in each country is listed in [Table TDI-7]. 

 See also 'TDI-103-All outpatient age and primary drug.xls' on distribution by country and 'General notes for interpreting data' on the Explanatory notes and help page

Sources:

 2006 Reitox national reports - Table TDI outpatient treatment centres. 

Page last updated: Monday, 12 November 2007